CD23 acts through the avb5 integrin to promote growth of human pre-B cell lines in an adhesion-independent manner. avb5 is expressed on normal B-cell precursors in the bone marrow. Soluble CD23 (sCD23), short CD23-derived peptides containing the arg-lys-cys (RKC) motif recognized by avb5 and anti-avb5 monoclonal antibodies (MAbs) all sustain growth of pre-B cell lines. The chemokine stromal cell-derived factor-1 (SDF-1) regulates key processes during B-cell development. SDF-1 enhanced the growth-sustaining effect driven by ligation of avb5 with anti-avb5 MAb 15F-11, sCD23 or CD23-derived RKC-containing peptides. This effect was restricted to B-cell precursors and was specific to SDF-1. The enhancement in growth was associated with the activation of extracellular signal-regulated kinase (ERK) and both these responses were attenuated by the MEK inhibitor U0126. Finally, platelet-derived growth factor also enhanced both avb5-mediated cell growth and ERK activation. The data suggest that adhesion-independent growth-promoting signals delivered to B-cell precursors through the avb5 integrin can be modulated by cross-talk with receptors linked to both G-protein and tyrosine kinase-coupled signalling pathways.
Introduction
B lymphopoiesis is a tightly regulated multi-stage process. The bone marrow microenvironment provides a variety of cytokines, chemokines, growth factors and adhesion molecules that co-ordinately regulate B-cell development. Perturbation of B-cell differentiation in the bone marrow leads to malignancies including acute lymphoblastic leukaemia (ALL). 1 The interaction between soluble CD23 (sCD23) and the integrin avb5 sustains growth of human pre-B cell lines derived from ALL patients. 2, 3 Human CD23, a 45-kDa type II transmembrane glycoprotein, can be cleaved from the cell surface to release a range of sCD23 proteins with cytokinelike activities. The cytokine-like activities include promoting the release of cytokines from monocytic cells, mediated by the aMb2, aXb2 4, 5 and avb3 integrins, 6 and influencing the survival and differentiation of centrocytes by binding to CD21. [7] [8] [9] Plasma sCD23 levels are low in normal subjects, but high levels are reported in inflammatory disorders such as rheumatoid arthritis and systemic lupus erythmatosus. 10 Particularly high levels of sCD23 with prognostic value are a hallmark of B-cell chronic lymphoblastic leukaemia. 11 The avb5 integrin, a member of the vitronectin receptor family, is expressed by bone marrow B-cell precursors. 2 The vitronectin receptor family members comprise the av chain in non-covalent association with one of five b-subunits (b1, b3, b5, b6 and b8) and bind a broad spectrum of ligands, including fibrinogen, fibronectin and vitronectin, typically by the recognition of arg-gly-asp motifs. [12] [13] [14] Vitronectin receptors have diverse roles in cell adhesion, migration and survival and are implicated in the growth of a number of cancer cells. The vitronectin receptors avb5 and avb3 are recognized CD23 receptors 2, 6 and avb5 recognizes an arg-lys-cys (RKC) motif on sCD23 in an adhesionindependent interaction. 2 The growth and survival of normal and leukaemic B-cell progenitors is dependent on intimate contact with bone marrow stromal layers [15] [16] [17] and the factors responsible for the proliferation of progenitor cells include both cellular adhesion molecules and soluble proteins. 15 The avb5-CD23 interaction could represent an important mechanism regulating the growth of B-cell precursors, in combination with other factors present in the bone marrow microenvironment.
Stromal cell-derived factor-1 (SDF-1 or CXCL12) is a member of the CXC chemokine family 18 that binds to CXCR4 and CXCR7 receptors. 19, 20 Gene inactivation of SDF-1 or CXCR4 in vivo causes embryonic lethality due to abnormal cerebral and gastrointestinal vasculatures and haematopoietic development. [21] [22] [23] [24] SDF-1 is the most powerful chemoattractant for undifferentiated human CD34 þ haematopoietic progenitors. 25, 26 Several studies have shown that SDF-1 activates the integrins LFA-1, VLA-4 and VLA-5, [27] [28] [29] [30] [31] and facilitates transendothelial migration, homing and engraftment of precursor B cells in the bone marrow. 31, 32 In addition to its established role in regulating cell motility, SDF-1 also plays a role in cell survival 33, 34 and proliferation, 35 often in synergy with other cytokines. 36 CXCR4 ligation by SDF-1 induces receptor internalization, elevation of cytoplasmic Ca 2 þ levels, activation of phosphatidylinositol 3-kinase (PI3K) and phosphorylation of MEK, extracellular signal-regulated kinase (ERK) and components of focal adhesion complexes in many cell types including B-cell precursors. [37] [38] [39] [40] [41] [42] [43] The well-established role of SDF-1 in B lymphopoiesis and in influencing integrin function makes it an attractive candidate for modulating avb5 function. The data in this report indicate that SDF-1 modulates the growth-sustaining function of avb5, by influencing ERK signalling downstream of both CXCR4 and avb5; platelet-derived growth factor (PDGF) also enhances avb5-mediated signalling. PDGF has been extensively studied in the context of integrin-growth factor receptor cross-talk 44 and we therefore assessed the role of PDGF together with other cytokines, in modulating avb5 function. The data show that biological responses activated through the avb5-CD23 interactions in early B-cell precursors are modulated by inputs from both G-protein-coupled and tyrosine kinase-linked receptors. 
Materials and methods

Antibodies and reagents
Cell lines and cell culture
The SMS-SB cell line was derived from a female patient presenting with ALL; 45 SMS-SB cells were cultured in PFHM supplemented with 2 mM fresh glutamine and 1% (w/v) penicillin and streptomycin at 37 1C in 5% CO 2 in air in a humidified atmosphere, at 2.5-5 Â 10 5 cells/ml. RS4; 11, 46 Blin-1, RAJI, Daudi and IB4 B cell lines were from laboratory stocks. Cell lines were maintained in RPMI-1640 medium supplemented with 10% (v/v) heat-inactivated foetal calf serum, 2 mM fresh glutamine, and penicillin and streptomycin, at 37 1C in a 5% CO 2 in air in a humidified atmosphere. hMSC-terttelomerized human stromal cell line was a gift from Dr M Kassem (Denmark) 47 and was maintained in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) heatinactivated foetal calf serum, 2 mM fresh glutamine, and penicillin and streptomycin. Normal human bone marrow was obtained from Lonza Biologics (Slough, UK). Aliquots were subjected to sterile sorting on a FACSAria instrument (BD Bioscience) using fluorescein isothiocyanate anti-k chain and PE-anti-CD19 monoclonal antibodies (MAbs) to obtain a fraction of cells enriched for B-cell precursors. For cultures with sCD23, peptides and anti-avb5 MAbs, the cells were propagated in medium supplemented with 2% (v/v) foetal calf serum and hMSC-tert stromal cells. Mononuclear cells were isolated from samples from ALL patients and were cultured in AIMV serum-free medium, hMSC-tert stromal cells and stimulants.
Cell growth assays SMS-SB cells were washed and then plated at a density of 2500 cells/100 ml culture (low cell density), a seeding density at which the cells are prone to apoptosis, 3 in 96-well microtitre assay plates in PFHM. All other cell lines were washed extensively in PFHM before culture at 5000 cells/100 ml cultures. Cultures were propagated in the presence or absence of cytokines, MAbs or peptides, at 37 1C for 72 h followed by the addition of 0.3 mCi/well [ 3 H]-TdR for 18 h before harvest; incorporation was determined by liquid scintillation spectrometry. For assays with bone marrow B cells or ALL cells, g-irradiated (30 Gy (3000 rad)) hMSC-tert stromal cells were plated at a density of 2 Â 10 5 cells/well at least 7 days before the addition of mononuclear cells. Fluorescence-activated cell-sorted human bone marrow B cells were plated at a density of 3000 cells/well on the stromal cells in RPMI-1640 medium supplemented with 2% (v/v) heat-inactivated foetal calf serum, 2 mM fresh glutamine, and penicillin and streptomycin. ALL cells were plated at the same cell density in AIMV serum-free medium. All cultures were established in triplicate. Cytokines were used at 0.5-32 nM and sCD23 was employed at 0.4-6 nM. In experiments using inhibitors, cells were incubated with the inhibitors (5-10 mM U0126, 50 mM LY294002 and 50 mM AMD3100) for 30 min at 37 1C before the introduction of stimuli.
Peptide biochemistry
CD23-derived peptides containing the RKC motif recognized by the avb5 integrin are biologically active. The peptides were used at 0.5-3.33 mM and are numbered according to their position in the original screening library. 2 The sequences of the peptides used in this study are no. 9, KWINFQRKC; no. 11, FQRKCYYFG; LP long peptide, KWINFQRKCYYFGKG. Peptide no. 8, PEKWINFQR; no. 41, SGSGGEFIWVDGS; and no. 34, SGSGHTGSWIGLR that lack the RKC motif and do not bind to avb5 were used as negative control peptides.
Flow cytometry
Cells were harvested and washed twice with ice-cold phosphate-buffered saline and resuspended at 5 Â 10 6 cells/ml. One hundred microlitres of cell suspension was stained with either biotinylated, unlabelled primary MAb or biotinylated CD23-derived peptides (10 mg/ml) for 30-60 min; unlabelled primary antibody was visualized using a secondary phycoerythrinconjugated anti-mouse IgG or, in the case of biotinylated antibody or peptides, streptavidin-phycoerythrin. For assay of apoptosis, approximately 1 Â 10 6 cells were washed twice with ice-cold phosphate-buffered saline and stained with 100 ml labelling buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid-KOH, pH 7.4, 150 mM NaCl, 5 mM CaCl 2 , 0.5 mg propidium iodide and 5 ml annexinV-fluorescein isothiocyanate) and incubated at room temperature for 20 min. The labelling buffer was aspirated and the cells were resuspended in 400 ml wash buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid-KOH, pH 7.4, 150 mM NaCl, 5 mM CaCl 2 ). Cells were analysed on an FACScan flow cytometer, using CellQuest software (Becton Dickinson, San Jose, CA, USA).
Western blot analysis
Approximately 3 Â 10 7 cells in PFHM were stimulated with either SDF-1 (250 ng/ml), sCD23 (160 ng/ml), LP (1 mg/ml), peptide no. 8 or 9 (5 mg/ml) or 15F-11 MAb (5 mg/ml) alone SDF-1 and PDGF enhance avb5 signalling in human pre-B cells M Acharya et al or in combination for specified time periods at 37 1C. Stimulation was stopped by the addition of RIPA buffer without detergents (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM ethylene glycol tetraacetic acid and 1 mM Na 3 VO 4 ). Cell pellets were lysed in RIPA buffer containing detergents and protease inhibitors (RIPA buffer as above plus 1% (w/v) NP40, 1 mM Na deoxycholate, 1 mM PMSF and 2 mg/ml leupeptin) and clarified by centrifugation at 13 000 g for 15 min. Protein concentrations were determined using the Bradford reagent (BioRad Laboratories Ltd, Hampstead, UK) with bovine serum albumin as a standard. Equal amounts of protein (30-40 mg) were loaded per lane on 4-12% NuPAGE Novex Bis-Tris polyacrylamide gradient gels (Invitrogen, Paisely, UK) and transferred onto nitrocellulose. Phosphorylated and total protein profiles were detected sequentially on the same membrane using specific primary antibodies, secondary antibodies conjugated to horseradish peroxidase and enhanced chemiluminescence (Pierce, Rockford, USA). Bands were quantified by densitometry using ImageJ software (HIN, Bethesda, MD, USA).
Results
SDF-1 enhances growth of pre-B cell lines induced by the ligation of avb5 integrin
The avb5-sCD23 interaction sustains the growth of human precursor B cell lines. 2 CD23-derived peptides containing the RKC motif recognized by the avb5 integrin and the 15F-11 MAb, which binds the assembled avb5 heterodimer, all sustain growth in a manner similar to sCD23. .01 indicate the significance in enhancement of proliferation with 250 ng/ml SDF-1 and avb5 stimulants when compared with avb5 stimulants alone. Data are representative of three independent experiments. (g) SMS-SB cells cultured in the presence or absence of 250 ng/ml SDF-1 (24 h) were stained for avb5 expression using the anti-avb5 MAbs P1F-6 and 15F-11. Fluorescence intensity histograms for the relevant avb5 MAb are represented by the grey shaded area and isotype control antibody staining is represented by the black line. LCD, low cell density; SDF-1, stromal cell-derived factor-1; [ peptide containing the RKC motif, but has no effect on the ability of peptide no. 34, which lacks the RKC tripeptide, to promote cell growth (Figure 1d ). SDF-1 also enhances cell growth stimulated by the LP, a particularly potent CD23-derived peptide containing the RKC motif (Figure 1e ). The CXCR4-specific antagonist AMD3100 was used to inhibit binding of SDF-1 to CXCR4. Figure 1f shows that after AMD3100 treatment, there is no difference in cell growth induced by LP in the presence or absence of SDF-1 in SMS-SB cells, indicating that the enhancement in LP-induced cell growth is through SDF-1 and CXCR4. There was no change in avb5 expression in cells treated with SDF-1 compared with untreated cells (Figure 1g) , nor was there any increase in peptide binding to treated cells (Supplementary Figure 1A) . Furthermore, the stimulation of avb5 with either LP or sCD23 did not influence CXCR4 expression (Supplementary Figure 1B) . Although the data show that SDF-1 can cooperate with soluble avb5-directed ligands to enhance growth of SMS-SB cells, it remains to be determined whether this reflects either inhibition of apoptosis, stimulation of cell division or a combination of both processes.
Enhancement of avb5-driven cell growth by SDF-1 is specific to B-cell precursors LP treatment) . Finally, the cell line IB4, which is low/negative for both CXCR4 and avb5 expression, shows no increase in cell growth following avb5 ligation with LP in the presence or absence of SDF-1 (Figure 2c) .
The cytokines IL-7, IL-11, IL-3 and IL-4 were also assessed to determine if any of them could enhance avb5-induced cell growth; none of these cytokines mimicked the ability of SDF-1 to enhance avb5-mediated cell growth (Figure 3) . IL-7 has no effect on LP-induced SMS-SB cell growth (Figure 3a) , and whereas IL-11 alone induces an increase in [
3 H]-TdR incorporation (Figure 3b) , it has no effect on avb5-regulated cell growth; neither IL-3 nor IL-4 enhances avb5-induced growth (Figure 3c and d). Growth responses to the different cytokines were tested using all of the different avb5-directed stimuli and none of the cytokines tested modulated avb5 expression (data not shown). 
Po0
.01 indicate a significant enhancement of cell growth with 250 ng/ml SDF-1 and avb5 stimulants when compared with avb5 stimulants alone. Data are representative of three independent experiments. LP, long peptide; sCD23, soluble CD23; SDF-1, stromal cell-derived factor-1.
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SDF-1 enhances ERK phosphorylation induced by sCD23 and other avb5 ligands
The signalling pathways that might regulate synergistic activation of cell growth by avb5 ligation and SDF-1 treatment were evaluated, with a focus on ERK phosphorylation as SDF-1 is known to target this pathway. 41 Treatment of SMS-SB cells with sCD23 promotes robust phosphorylation of ERK at 30-60 min (Figure 4a ). SDF-1 alone provokes an early, modest increase in phospho-ERK levels (Figure 4a ). By contrast, co-stimulation of SMS-SB cells with SDF-1 and sCD23 stimulates a very robust ERK phosphorylation that is sustained until 10 min poststimulation, yielding phospho-ERK levels that are some 15-fold greater than either stimulus alone (Figure 4a and b) . The 15F11 MAb induces ERK phosphorylation at 10-30 min post-stimulation, whereas co-stimulation with SDF-1 and 15F11 promotes an earlier onset of ERK phosphorylation that is sustained to 30 min (Figure 4c ). The RKC-containing CD23-derived peptide no. 9 behaves similarly, inducing a modest response by itself and a more rapid and sustained response when added together with SDF-1; peptide no. 8, which lacks the RKC motif, fails to induce significant phosphorylation either alone or in association with SDF-1 (Figure 4d) . Finally, the RKC-containing pentadecameric LP induces a sustained and robust ERK phosphorylation that is enhanced by SDF-1 co-stimulation (Figure 4e ). LP has an affinity for avb5 that is an order of magnitude greater than that of CD23 itself (B10 À7 vs 6 Â 10 À6 M), 2 and this greater affinity may explain the higher and more sustained levels of ERK phosphorylation noted with LP. The data are consistent with the interpretation that ligation of avb5 by a soluble ligand alone promotes a modest level of ERK phosphorylation that is enhanced by SDF-1; SDF-1 also drives a more rapid elevation in ERK phosphorylation when added together with a soluble avb5 ligand.
We used the MEK inhibitor U0126 and the PI3K inhibitor LY294002 to further investigate the specificity of the ERK signalling pathway in avb5-mediated functions. Pre-treatment of SMS-SB cells with U0126 completely abolishes the effect of sCD23-and CD23-derived peptides on cell growth (Figure 5a ). Moreover, U0126 inhibits basal survival of SMS-SB cells in lowdensity cultures within a few hours of initiation of the culture. U0126 treatment also abrogates the ERK phosphorylation driven by SDF-1 or sCD23 individually and also completely prevents the enhancement of ERK phosphorylation observed with SDF-1 and sCD23 co-stimulation (Figure 5c ). The PI3K inhibitor LY294002 also attenuates growth of SMS-SB cells in response to avb5 ligation, but this inhibition is less complete than that observed with U0126 (Figure 5b) . Thus, after 48 h of LP stimulation, a small increase in [ 3 H]-TdR incorporation remains evident in cells pretreated with LY294002, whereas no growth is detectable after 12 h of U0126 treatment (Figure 5a and b) . Analysis of SMS-SB cell survival using annexinV/propidium iodide staining showed that U0126 treatment results in a higher proportion of annexinV/ propidium iodide double-positive cells than LY294002 treatment after a 12 h period (Figure 5d ), illustrating that U0126 leads to increased apoptosis in SMS-SB cells relative to LY294002 treatment. This underscores the importance of the ERK signalling pathway in the survival of SMS-SB cells.
PDGF enhances avb5-driven growth of pre-B cell lines
PDGF stimulates SMS-SB cell growth and the cells express PDGF receptor-b. 48 Figure 6a and b, respectively, show that Response of normal bone marrow B cells and ALL cells to soluble avb5-specific stimulation B-cell precursors from the bone marrow that are positive for avb5 integrin also express CXCR4, and cells from patients with ALL also express the avb5 integrin and CXCR4. Growth of BM-derived B-cell precursors and ALL cells was investigated to relate the data from pre-B cell lines with their normal and malignant counterparts in the bone marrow. The ability of CD19 þ /k À fluorescence-activated cell-sorted B-cell precursors isolated from bone marrow aspirates to respond to stimulation with soluble avb5-directed ligands was assessed. A robust incorporation of thymidine was stimulated by both LP (5 mg/ml) and by sCD23 (250 ng/ml) (Figure 7a) , whereas a control peptide devoid of the RKC motif, peptide no. 8, was without effect; the cells also responded to the 15F11 MAb, indicating the specificity of avb5 integrin in mediating cell growth (data not shown). Second, both sCD23 and LP promote growth of ALL cells (avb5 þ ) above background levels (Figure 7b) , and co-stimulation with SDF-1 (Figure 7c ) or PDGF (Figure 7d ) with lower concentrations of sCD23 resulted in significant enhancement in cell growth. The data show that normal bone marrowderived B-cell precursors and patient-derived ALL cells can respond to sCD23 and related ligands. The growth responses were not as robust as those noted in the cell line models and although we observed enhancement in cell growth with the addition of SDF-1 and PDGF, the [ 3 H]-TdR incorporation induced by suboptimal concentration of sCD23 in these cases was minimal.
Discussion
It is well established that chemokines dynamically regulate the positioning of cells of the immune system by influencing the structure of integrin molecules to ensure that cells attracted to a specific niche are retained there through adhesion reactions with tissue matrix proteins. Chemokines can also positively influence signalling through integrins in such adhesion-dependent interactions, as exemplified by the action of SDF-1 on haematopoietic precursors at the level of the VLA-4-ICAM1 interaction. 31, 32 This report shows that SDF-1 positively influences signalling events delivered to integrins in a soluble, adhesion-independent manner. Thus, ligation of avb5 using specific MAbs, sCD23 or peptides derived from sCD23 provokes ERK phosphorylation and growth responses in B-cell precursors 
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that are enhanced by SDF-1. PDGF also enhances signalling delivered by soluble ligation of avb5, suggesting that both tyrosine kinase-and G-protein-coupled receptor-linked pathways modulate adhesion-independent signalling by avb5. Growth of SMS-SB cells stimulated with sCD23 was enhanced by the addition of SDF-1 and similar responses were noted with sCD23-derived peptides (containing the RKC motif recognized by avb5) and the anti-avb5 MAb 15F-11, all of which promote growth of these cells. SDF-1 acts through CXCR7 as well as through CXCR4, and to address the specificity of CXCR4 in enhancing avb5-mediated signals, the binding of SDF-1 to CXCR4 was blocked using the CXCR4 antagonist AMD3100. 49, 50 AMD3100 completely abolished the ability of SDF-1 to enhance avb5-mediated SMS-SB cell growth ( Figure 1f) ; pre-treatment of SMS-SB cells with the anti-CXCR4 MAb (12G5) also inhibited the action of SDF-1 (data not shown). There is growth of SMS-SB cells with AMD3100 treatment alone (Figure 1f ). AMD3100 has been extensively used as CXCR4 antagonist; however, it has also been suggested to be a weak partial agonist, 51 which might partly explain the small apparent growth effect with AMD3100 alone. However, in the presence of SDF-1, AMD3100 clearly acts as a CXCR4 antagonist. Importantly, AMD3100 has no effect on LP-induced cell growth but blocks the enhancement in growth with LP and SDF-1. Finally, the assessment of CXCR7 expression illustrated that SMS-SB cells have a modest level of CXCR7, Blin-1 cells have no CXCR7 but express CXCR4, whereas IB4 cells lack CXCR4 but express CXCR7; IB4 cells do not respond to SDF-1 stimulation (data not shown). Taken together, the data are consistent with the interpretation that SDF-1 mediates its effect on avb5-stimulated cell growth by CXCR4.
Higher levels of CXCR4 expression do not influence the lack of response to avb5 ligation noted in the more mature cell lines, and this is consistent with data showing that although B-cell precursors express higher levels of CXCR4 with increasing maturation, the cell's chemotactic response to SDF-1 itself is SDF-1 and PDGF enhance avb5 signalling in human pre-B cells M Acharya et al apparently blunted. Thus, CXCR4 is continuously expressed by B cells and, as the cells mature and begin to express surface IgM, the chemotactic response to SDF-1 is lost despite the sustained expression of CXCR4. [52] [53] [54] In agreement with these results, our data support the notion that avb5-mediated cell growth is important at particular stages of B-cell development and is modulated by SDF-1 in a stage-specific manner.
SMS-SB cells undergo apoptosis in low-density culture conditions. 3 The inhibition of cell growth by U0126 shows that basal ERK phosphorylation is necessary for the survival of SMS-SB cells; in the presence of U0126, the cells rapidly undergo apoptosis. ERK phosphorylation observed following sCD23, RKC-containing peptide or 15F-11 treatment shows that growth induced by the ligation of avb5 with sCD23 is regulated through the ERK signalling pathway. The enhancement in cell growth noted with SDF-1 and sCD23 correlated well with a sustained increase in ERK phosphorylation. This was verified by similar enhancements observed when CD23-derived peptides and 15F-11 antibody were used as stimuli. However, it cannot be excluded that other signalling pathways might be involved in regulating SMS-SB cell growth, and the observation that LY294002 inhibited the enhancement of avb5-mediated cell growth by SDF-1 indicates that AKT has the potential to regulate adhesion-independent signalling by avb5. This would be consistent with studies that show that SDF-1 activates both ERK and AKT 38, 55, 56 and merits further investigation. Many cytokines are known to modulate integrin function and B-cell precursor survival, but no similar enhancement of avb5-mediated cell growth was promoted by the cytokines IL-7, IL-3, IL-4 and IL-11 at the concentrations used. It has been shown that SDF-1, IL-3 and IL-7 induce proliferation of ALL cells co-cultured with stromal cells; IL-7 alone did not induce ERK activation but there was a synergistic ERK activation following IL-7 and SDF-1 co-stimulation. 57 However, in the co-culture studies, the ALL cells were propagated on stromal cells and effects on ERK and other signalling pathways would have been affected by multiple adhesion contacts between the ALL cells and stromal cells. Therefore, the data from the ALL-stromal cell co-culture model illustrate convincingly that ERK phosphorylation can occur in an adhesion-dependent manner. 57 In our own studies of normal bone marrow B cells and ALLderived cells, cultures that lacked serum or stromal cell support failed to support any growth of the cells. Using bone marrow B-cell precursors propagated on irradiated stromal cells, we were able to show that avb5 ligation by sCD23 induces growth response in these precursors, similar to that seen in cell lines. The importance of this was further assessed in ALL cells to investigate if SDF-1 could enhance this avb5-mediated growth response. Cultures with stromal cells supported modest growth of ALL cells exposed to avb5 stimulants alone and some degree of enhancement of sCD23-driven growth of ALL cells by SDF-1 was achieved. The data indicate that normal marrowcytes respond to sCD23 and that in ALL cells, some additive effect of avb5-directed ligands and other receptors can be elicited. The finding that sCD23 can induce ERK phosphorylation in B-cell precursor cell lines is consistent with data from studies of monocytes that showed strong ERK responses to integrin ligation and sCD23 stimulation, 58, 59 and it remains to be determined Finally, PDGF enhanced the cell growth induced by avb5 in a manner similar to that observed with SDF-1. Interestingly, a previous study shows that early pre-B cells, but not mature B cells, express the PDGF receptor-b, and PDGF was shown to promote proliferation of these cells but not immature B cells. 60 A number of studies, particularly in adherent cell systems, have shown a cross-talk between growth factors and integrin signalling, and synergy between growth factors and cell adhesion has been observed in the activation of the MAPK 61, 62 and PI3K/AKT pathways. 63 Moreover, PDGF has previously been shown to interact physically with the avb3 integrin to stimulate proliferation of oligodendrocytes by the activation of the integrin in an adhesion-dependent manner. 64 Therefore, it is plausible that PDGF and avb5 also interact to promote adhesion-independent proliferation in B-cell precursors. Our data indicate that avb5 synergizes with two distinct signalling pathways, through a tyrosine kinase receptor (PDGF receptor-b) and a G-protein-coupled receptor (CXCR4), to promote ERK phosphorylation and pre-B-cell growth. It will be important to determine the common molecules downstream of both these pathways leading to ERK phosphorylation to understand further the mechanisms involved in avb5-mediated cell growth.
The model emerging from these data suggests a role for avb5 integrin in B-cell precursor survival and growth that can be modulated by other biological effectors such as SDF-1 and PDGF. This may have important implications for growth of normal and neoplastic B cells. B-cell development in different compartments of the haematopoietic microenvironment is accompanied by stage-specific changes that are critical for proliferation and differentiation into later developmental stages.
A range of adhesion and signalling molecules controlling each stage are not only key to understanding the progression into the developmental pathway but also in developing therapies for neoplasias that arise in different stages of B-cell development.
